Aortic Complications of Giant Cell Arteritis: A Diagnostic and Management Dilemma
Nick Butler M.B.Ch.B.
Department of Cardiac Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorJulie Mundy F.R.A.C.S.
Department of Cardiac Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorPallav Shah F.R.A.C.S.
Department of Cardiac Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorNick Butler M.B.Ch.B.
Department of Cardiac Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorJulie Mundy F.R.A.C.S.
Department of Cardiac Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorPallav Shah F.R.A.C.S.
Department of Cardiac Surgery, Princess Alexandra Hospital, Brisbane, Queensland, Australia
Search for more papers by this authorConflict of interest: None.
Abstract
Abstract We describe three giant cell aortitis patients who were operatively managed at our institution over the last seven years and review the recent relevant literature to highlight the specific features of the disease and the salient points of management in relation to the cardiac surgeon. (J Card Surg 2010;25:572-581)
REFERENCES
- 1 Klein RG, Hunder GG, Stanson AW, et al: Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975; 83(6): 806-812.
- 2 Piette AM, Bletry O: Involvement of large arteries by Horton's disease. Rev Prat 1999; 49(6): 609-612.
- 3 Pacini D, Leone O, Turci S, et al: Incidence, etiology, histologic findings, and course of thoracic inflammatory aortopathies. Ann Thorac Surg 2008; 86(5): 1518-1523.
- 4 Virmani R, Burke, AP: Nonatherosclerotic diseases of the aorta and miscellaneous diseases of the main pulmonary arteries and large veins. In MD Silver, AI Gotloeb, FJ Schoen (eds): Cardiovascular Pathology. Churchill Livingstone, Philadelphia , 2001, pp. 277-288.
- 5 Hunder GG, Bloch DA, Michel BA, et al: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33(8): 1122-1128.
- 6 Gelsomino S, Romagnoli S, Gori F, et al: Annuloaortic ectasia and giant cell arteritis. Ann Thorac Surg 2005; 80(1): 101-105.
- 7 Bongartz T, Matteson EL: Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 2006; 18(1): 10-17.
- 8 Evans JM, O’Fallon WM, Hunder GG: Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995; 122(7): 502-507.
- 9 Evans JM, Bowles CA, Bjornsson J, et al: Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum 1994; 37(10): 1539-1547.
- 10 Blockmans D: Utility of imaging studies in assessment of vascular inflammation. Cleve Clin J Med 2002; 69(Suppl 2): SII95-SII99.
- 11 Yamada I, Nakagawa T, Himeno Y, et al: Takayasu arteritis: Evaluation of the thoracic aorta with CT angiography. Radiology 1998; 209(1): 103-109.
- 12 Khoury JA, Hoxworth JM, Mazlumzadeh M, et al: The clinical utility of high resolution magnetic resonance imaging in the diagnosis of giant cell arteritis: A critically appraised topic. Neurologist. 2008; 14(5): 330-335.
- 13 Bansal MK, Maraj S, Chewaproug D, et al: Myocardial contusion injury: Redefining the diagnostic algorithm. Emerg Med J 2005; 22(7): 465-469.
- 14 Brooks SW, Young JC, Cmolik B, et al: The use of transesophageal echocardiography in the evaluation of chest trauma. J Trauma 1992; 32(6): 761-765; discussion 5-8.
- 15 Zehr KJ, Mathur A, Orszulak TA, et al: Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis. Ann Thorac Surg 2005; 79(5): 1512-1517.
- 16 Takagi H, Mori Y, Iwata H, et al: Nondissecting aneurysm of the thoracic aorta with arteritis in systemic lupus erythematosus. J Vasc Surg 2002; 35(4): 801-804.
- 17 Weyand CM, Kaiser M, Yang H, et al: Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum 2002; 46(2): 457-466.
- 18 Nesher G, Berkun Y, Mates M, et al: Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. 2004; 50(4): 1332-1337.
- 19 Lee MS, Smith SD, Galor A, et al: Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006; 54(10): 3306-3309.
- 20 Narvaez J, Bernad B, Gomez-Vaquero C, et al: Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis. Clin Exp Rheumatol 2008; 26(3 Suppl 49): S57-S62.
- 21 Mukhtyar C, Guillevin L, Cid MC, et al: EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68(3): 318-323.
- 22 Liu G, Shupak R, Chiu BKY: Aortic dissection in giant cell arteritis. Semin Arthritis Rheum 1995; 25(3): 160-171.
- 23 Berry MF, Woo YJ: Repair of acute type A aortic dissection associated with temporal arteritis. Ann Thorac Surg 2003; 76(5): 1717-1718.
- 24 Haddad F, El-Rassi I, Haddad FG. Aorto-atrial fistula 10 days after dissection repair in giant cell arteritis. Ann Thorac Surg 2008; 86(5): 1672-1674.
- 25 Koga T, Miyashita T, Matsuoka Y, et al: Acute dissecting thoracic aortic aneurysm in a patient with polymyalgia rheumatica. Am J Med Sci 2007; 334(5): 386-388.
- 26 Maksimowicz-McKinnon K, Clark TM, Hoffman GS: Takayasu arteritis and giant cell arteritis: A spectrum within the same disease? Medicine (Baltimore) 2009; 88(4): 221-226.
- 27 Baril DT, Carroccio A, Palchik E, et al: Endovascular treatment of complicated aortic aneurysms in patients with underlying arteriopathies. Ann Vasc Surg 2006; 20(4): 464-471.
- 28 Engelke C, Sandhu C, Morgan RA, et al: Endovascular repair of thoracic aortic aneurysm and intramural hematoma in giant cell arteritis. J Vasc Interv Radiol 2002; 13(6): 625-629.
- 29 Porcu P, Chavanon O, Thony F, et al: Unusual aortic stent complication after endovascular repair of the descending thoracic aorta in type B dissection in a patient with giant-cell arteritis. Interact CardioVasc Thorac Surg 2009; 8(2): 287-289.
- 30 Isselbacher EM: Thoracic and abdominal aortic aneurysms. Circulation 2005; 111(6): 816-828.
- 31 Bonow RO, Carabello BA, Kanu C, et al: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114(5): e84-e231.
- 32 Vahanian A, Baumgartner H, Bax J, et al: Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28(2): 230-268.
- 33 Bachet J: Acute type A aortic dissection: Can we dramatically reduce the surgical mortality? Ann Thorac Surg 2002; 73(3): 701-703.
- 34 Niclauss L, Letovanec I, Chassot PG, et al: Acute aortic valve insufficiency and cardiogenic shock due to an isolated giant cell inflammation of the aortic valve leaflets: Case report and review of the literature. J Heart Valve Dis 2008; 17(3): 343-347.